| __timestamp | Viking Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22223073 | 11768000 |
| Thursday, January 1, 2015 | 6966842 | 15152000 |
| Friday, January 1, 2016 | 9000499 | 19828000 |
| Sunday, January 1, 2017 | 13741186 | 25573000 |
| Monday, January 1, 2018 | 19040000 | 23634000 |
| Tuesday, January 1, 2019 | 23559000 | 38845000 |
| Wednesday, January 1, 2020 | 31931000 | 50523000 |
| Friday, January 1, 2021 | 44981000 | 75463000 |
| Saturday, January 1, 2022 | 54234000 | 105767000 |
| Sunday, January 1, 2023 | 63806000 | 167512000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viking Therapeutics, Inc. and Xenon Pharmaceuticals Inc. have demonstrated significant growth in their R&D investments.
From 2014 to 2023, Viking Therapeutics increased its R&D expenses by nearly 187%, reflecting its strategic focus on advancing its therapeutic pipeline. The company's R&D spending grew from approximately $22 million in 2014 to over $63 million in 2023, showcasing a robust commitment to innovation.
Xenon Pharmaceuticals, on the other hand, has shown an even more impressive trajectory, with a staggering 1,324% increase in R&D expenses over the same period. Starting at around $12 million in 2014, their investment surged to approximately $168 million by 2023, underscoring their aggressive pursuit of groundbreaking treatments.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments are pivotal for long-term success.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Research and Development Investment: Incyte Corporation vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
R&D Insights: How Ascendis Pharma A/S and Xenon Pharmaceuticals Inc. Allocate Funds
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.